MEDP

Q: What is the price of Medpace Holdings (MEDP) today?

The price of Medpace Holdings (MEDP) today is US$ 528,07, with a variation of 54.01% compared to the last year. The price of Medpace Holdings (MEDP) started the year trading around US$ 332,23 and today it is at US$ 528,07. Follow the real-time price chart, the historical price of Medpace Holdings (MEDP), and stock data from Ibovespa and international markets.

Q: When does Medpace Holdings (MEDP) pay dividends?

Medpace Holdings (MEDP) não distribuiu dividendos no último ano.

Q: Medpace Holdings (MEDP) is it worth it?

Currently, Medpace Holdings (MEDP) is priced at US$ 528,07, with a P/E of 35,27%, representing a deviation of 33,25% from its historical average P/E. In the last year, the stock showed a variation of 54.01% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 54,01%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Medpace Holdings (MEDP)?

Investing in stocks of Medpace Holdings (MEDP) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Medpace Holdings (MEDP) yield today?

The yield of Medpace Holdings (MEDP) was 6,07% in the last month, 54,01% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of Medpace Holdings (MEDP) today, the total investment would be US$ 52.807,00, based on the current price of US$ 528,07.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 81.328,06In 5 years: US$ 52.807,00In 10 years: 52.807,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Medpace Holdings Inc.

Price

US$ 528,07

variation (12m)

54,01%

p/l

35,27

p/vp

84,34

DIVIDEND YIELD

0,00%

price MEDP

BVMF

MEDP

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of MEDP

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

6,07%

3 months

69,32%

1 year

54,01%

2 years

128,58%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

6,07%

3 months

68,70%

1 year

47,26%

2 years

108,63%

5 years

0,00%

10 years

0,00%

Indicators MEDP

check out the fundamentals of Medpace Holdings shares

P/E

35,27

Sector: -3,49 Industry: -3,49

P/SALES RATIO (PSR)

6,31

Sector: -4,23 Industry: -4,23

P/BV

84,34

Sector: 1,90 Industry: 1,90

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

26,22%

Sector: -63,54% Industry: -63,54%

ROE

239,12%

Sector: -70,19% Industry: -70,19%

ROIC

18,90%

Sector: -2.095,92% Industry: -2.095,92%

NET MARGIN

17,90%

Sector: -41,67% Industry: -41,67%

GROSS MARGIN

31,14%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

21,36%

Sector: -41,04% Industry: -41,04%

P/EBITDA

27,95

Sector: -3,69 Industry: -3,69

P/EBIT

29,57

Sector: -3,68 Industry: -3,68

P/ASSET

9,25

Sector: 1,42 Industry: 1,42

BVPS

5,94

Sector: 1,85 Industry: 1,85

EPS

14,21

Sector: -2,19 Industry: -2,19

EQUITY / ASSETS

0,11

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

19,99%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

21,15%

Sector: - Industry: -

FAIR PRICE OF Medpace Holdings ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 528,07

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-91,75%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

MEDP indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,99	5,85	32,50%	2,66%	US$ 458,87 B	27,75%
PFE	15,32	1,58	10,33%	6,90%	US$ 140,87 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	15,47	9,74	62,99%	2,96%	US$ 253,17 B	34,74%
MRK	12,21	4,40	36,03%	3,77%	US$ 215,83 B	28,16%
AZN	28,13	5,85	20,79%	1,85%	US$ 262,04 B	16,23%
BMY	17,14	5,05	29,44%	5,67%	US$ 88,25 B	10,71%
GILD	20,79	7,45	35,82%	2,68%	US$ 145,89 B	24,71%
ZTS	23,71	12,62	53,20%	1,37%	US$ 62,79 B	28,00%
HALO	13,25	23,31	175,93%	0,00%	US$ 7,76 B	48,21%
REGN	13,15	1,98	15,06%	0,47%	US$ 59,29 B	31,83%
AMGN	29,90	21,01	70,29%	3,24%	US$ 156,09 B	14,67%
VRTX	28,91	6,10	21,11%	0,00%	US$ 104,80 B	31,22%
MCK	25,75	-110,60	-429,55%	0,39%	US$ 95,44 B	0,97%
CAH	26,89	-14,13	-52,54%	1,30%	US$ 37,22 B	0,60%
ADMA	16,91	8,80	52,03%	0,00%	US$ 3,50 B	43,51%
BIIB	12,13	1,22	10,08%	0,00%	US$ 21,55 B	17,46%

comparison of MEDP with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History MEDP

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Medpace Holdings

Medpace Holdings Inc.

Average user rating I10

4.0 (4 people)

Estados Unidos

11 years

Foundation: 2014

2016

Year of debut on the stock exchange - 9 years

3.500

Employees

The Company Medpace Holdings Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 14,54 Billions, having a net worth of $ 172,35 Milhões.

With a total of 3.500 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 2,30 Billions, which generated a profit in the amount of $ 412,13 Milhões.

As for its main indicators, the Company has a P/E ratio of 35,27, a P/BV ratio of 84,34 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker MEDP.

Market value

US$ 14,54 Billions

Net worth

US$ 172,35 Milhões

US$ 172.350.000,00

Assets

US$ 1,57 Billion

US$ 1.571.670.000,00

Total Number of Shares

29,00 Milhões

29.000.000

Average Daily Trading Volume

US$ 326,77 Thousand

US$ 326.767,28

Sector

Health Care

Industry

Biotechnology

MEDP

MEDP revenue and profits

MEDP results

DRAG THE FRAME TO SEE MORE DATA

MEDP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 786,00 55,04% (12M)

P/L

25,75

0,39%

ROE

-429,55%

P/VP

-110,60

CAH - Cardinal Health

US$ 156,41 41,14% (12M)

P/L

26,89

1,30%

ROE

-52,54%

P/VP

-14,13

JNJ - Johnson & Johnson

US$ 193,22 20,80% (12M)

P/L

17,99

2,66%

ROE

32,50%

P/VP

5,85

MRK - Merck & Co.

US$ 84,79 --19,11% (12M)

P/L

12,21

3,77%

ROE

36,03%

P/VP

4,40

ABBV - AbbVie

US$ 229,57 26,80% (12M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,51 --7,69% (12M)

P/L

15,32

6,90%

ROE

10,33%

P/VP

1,58

AZN - AstraZeneca

US$ 84,69 10,53% (12M)

P/L

28,13

1,85%

ROE

20,79%

P/VP

5,85

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 786,00 55,04% (12 M)

P/L

25,75

0,39%

ROE

-429,55%

P/VP

-110,60

CAH - Cardinal Health

US$ 156,41 41,14% (12 M)

P/L

26,89

1,30%

ROE

-52,54%

P/VP

-14,13

JNJ - Johnson & Johnson

US$ 193,22 20,80% (12 M)

P/L

17,99

2,66%

ROE

32,50%

P/VP

5,85

MRK - Merck & Co.

US$ 84,79 --19,11% (12 M)

P/L

12,21

3,77%

ROE

36,03%

P/VP

4,40

ABBV - AbbVie

US$ 229,57 26,80% (12 M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,51 --7,69% (12 M)

P/L

15,32

6,90%

ROE

10,33%

P/VP

1,58

AZN - AstraZeneca

US$ 84,69 10,53% (12 M)

P/L

28,13

1,85%

ROE

20,79%

P/VP

5,85

Frequently Asked Questions

What is the price of Medpace Holdings (MEDP) today?

The price of Medpace Holdings (MEDP) today is US$ 528,07, with a variation of 54.01% compared to the last year. The price of Medpace Holdings (MEDP) started the year trading around US$ 332,23 and today it is at US$ 528,07. Follow the real-time price chart, the historical price of Medpace Holdings (MEDP), and stock data from Ibovespa and international markets.

When does Medpace Holdings (MEDP) pay dividends?

Medpace Holdings (MEDP) não distribuiu dividendos no último ano.

Medpace Holdings (MEDP) is it worth it?

Currently, Medpace Holdings (MEDP) is priced at US$ 528,07, with a P/E of 35,27%, representing a deviation of 33,25% from its historical average P/E. In the last year, the stock showed a variation of 54.01% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 54,01%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Medpace Holdings (MEDP)?

Investing in stocks of Medpace Holdings (MEDP) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Medpace Holdings (MEDP) yield today?

The yield of Medpace Holdings (MEDP) was 6,07% in the last month, 54,01% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 stocks of Medpace Holdings (MEDP) today, the total investment would be US$ 52.807,00, based on the current price of US$ 528,07.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 81.328,06
In 5 years: US$ 52.807,00
In 10 years: 52.807,00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

MEDP

Medpace Holdings Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of MEDP

check out the fundamentals of Medpace Holdings shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Medpace Holdings

Medpace Holdings Inc.

Estados Unidos

11 years

2016

3.500

PROFIT X PRICE MEDP

MEDP results

MEDP cash flow

evolution of assets - MEDP

MEDP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions